Bender Robert & Associates’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.6M Sell
68,645
-3,779
-5% -$1.91M 7.59% 3
2025
Q4
$41M Sell
72,424
-528
-0.7% -$281K 8.52% 3
2025
Q3
$32.6M Sell
72,952
-445
-0.6% -$214K 7.05% 3
2025
Q2
$39.9M Sell
73,397
-1,646
-2% -$861K 8.9% 3
2025
Q1
$37.2M Buy
75,043
+2,382
+3% +$1.32M 9.38% 3
2024
Q4
$37.9M Sell
72,661
-11,754
-14% -$6.12M 9.15% 3
2024
Q3
$41.5M Buy
+84,415
New +$39.3M 8.81% 3
2024
Q2
Sell
-87,789
Closed -$35M 63
2024
Q1
$35M Sell
87,789
-1,115
-1% -$421K 8.21% 3
2023
Q4
$30M Sell
88,904
-427
-0.5% -$127K 7.56% 3
2023
Q3
$26.1M Sell
89,331
-1,009
-1% -$315K 7.63% 3
2023
Q2
$30.9M Sell
90,340
-2,524
-3% -$764K 8.53% 3
2023
Q1
$23.7M Sell
92,864
-694
-0.7% -$171K 7.35% 2
2022
Q4
$24.8M Sell
93,558
-1,218
-1% -$297K 9.28% 2
2022
Q3
$17.8M Buy
94,776
+536
+0.6% +$115K 6.88% 3
2022
Q2
$18.9M Sell
94,240
-632
-0.7% -$148K 7.23% 2
2022
Q1
$28.6M Buy
94,872
+63,161
+199% +$18.5M 8.15% 2
2021
Q4
$31.5M Sell
31,711
-63,422
-67% -$21.8M 9.1% 2
2021
Q3
$31.5M Sell
95,133
-1,170
-1% -$393K 9.02% 2
2021
Q2
$29.5M Sell
96,303
-639
-0.7% -$179K 8.39% 2
2021
Q1
$23.9M Buy
96,942
+1,767
+2% +$445K 7.68% 3
2020
Q4
$26M Sell
95,175
-1,398
-1% -$347K 8.26% 2
2020
Q3
$22.8M Sell
96,573
-1,431
-1% -$321K 8.18% 3
2020
Q2
$18.6M Sell
98,004
-1,023
-1% -$183K 7.36% 4
2020
Q1
$16.3M Sell
99,027
-864
-0.9% -$158K 8.71% 2
2019
Q4
$19.7M Sell
99,891
-1,002
-1% -$188K 8.88% 2
2019
Q3
$18.2M Sell
100,893
-579
-0.6% -$100K 9.08% 2
2019
Q2
$17.8M Sell
101,472
-1,611
-2% -$276K 8.47% 2
2019
Q1
$19.6M Sell
103,083
-921
-0.9% -$164K 9.61% 2
2018
Q4
$16.6M Sell
104,004
-1,155
-1% -$196K 9.59% 2
2018
Q3
$20.1M Sell
105,159
-315
-0.3% -$55.9K 9.15% 2
2018
Q2
$16.8M Sell
105,474
-2,511
-2% -$383K 8.82% 2
2018
Q1
$14.9M Sell
107,985
-5,106
-5% -$713K 8.25% 2
2017
Q4
$13.8M Sell
113,091
-231,681
-67% -$29M 7.62% 2
2017
Q3
$13.4M Buy
344,772
+225,135
+188% +$24.5M 7.67% 2
2017
Q2
$12.4M Sell
119,637
-540
-0.4% -$51.9K 7.63% 2
2017
Q1
$10.2M Sell
120,177
-2,457
-2% -$194K 6.6% 3
2016
Q4
$8.64M Sell
122,634
-3,465
-3% -$255K 6.12% 3
2016
Q3
$10.2M Sell
126,099
-2,817
-2% -$216K 6.71% 3
2016
Q2
$9.47M Sell
128,916
-2,547
-2% -$179K 6.69% 2
2016
Q1
$8.78M Sell
131,463
-5,454
-4% -$338K 5.94% 5
2015
Q4
$8.31M Sell
136,917
-1,377
-1% -$77.3K 5.32% 5
2015
Q3
$7.06M Sell
138,294
-3,168
-2% -$179K 4.78% 6
2015
Q2
$7.62M Sell
141,462
-342
-0.2% -$19.1K 4.52% 6
2015
Q1
$7.96M Sell
141,804
-18
-0% -$1.02K 4.64% 6
2014
Q4
$8.34M Sell
141,822
-1,314
-0.9% -$73.2K 5.46% 5
2014
Q3
$7.34M Sell
143,136
-1,044
-0.7% -$51.8K 5.11% 5
2014
Q2
$6.6M Sell
144,180
-873
-0.6% -$38.5K 4.67% 7
2014
Q1
$7.06K Sell
145,053
-3,006
-2% -$142K 4.73% 7
2013
Q4
$6.32M Sell
148,059
-882
-0.6% -$37.1K 4.75% 7
2013
Q3
$6.23M Sell
148,941
-918
-0.6% -$40.5K 4.88% 6
2013
Q2
$8.43M Buy
+149,859
New +$8.26M 7.24% 2

Other funds holding ISRG

Bender Robert & Associates's ISRG Position: Q1 2026 in Review

Bender Robert & Associates reduced its Intuitive Surgical (ISRG) stake by 5.2% in Q1 2026, selling an estimated $1.91M and leaving 68,645 shares worth $31.6M. The position accounts for 7.59% of the portfolio, ranked #3.

Bender Robert & Associates first reported a position in ISRG in Q2 2013 and has held it in 51 quarters since. The position peaked at $41.5M in Q3 2024. 2,304 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Bender Robert & Associates held 68,645 shares of Intuitive Surgical worth $31.6M as of Q1 2026.
  • Bender Robert & Associates sold 3,779 Intuitive Surgical shares in Q1 2026, an estimated $1.91M.
  • Intuitive Surgical made up 7.59% of Bender Robert & Associates's portfolio in Q1 2026, its #3 holding.
  • Bender Robert & Associates first reported a position in Intuitive Surgical in Q2 2013 and has held it in 51 quarters since.
  • Bender Robert & Associates's Intuitive Surgical position peaked at $41.5M in Q3 2024.
  • 2,304 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Bender Robert & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.